NASDAQ:OM • US6901452069
The current stock price of OM is 3.17 USD. Today OM is down by -2.76%. In the past month the price decreased by -30.64%. In the past year, price decreased by -60.7%.
ChartMill assigns a technical rating of 0 / 10 to OM. When comparing the yearly performance of all stocks, OM is a bad performer in the overall market: 92.72% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to OM. While OM seems to be doing ok healthwise, there are quite some concerns on its profitability.
On February 11, 2026 OM reported an EPS of -0.84 and a revenue of 28.87M. The company missed EPS expectations (-27.93% surprise) and beat revenue expectations (5.19% surprise).
13 analysts have analysed OM and the average price target is 10.71 USD. This implies a price increase of 237.85% is expected in the next year compared to the current price of 3.17.
For the next year, analysts expect an EPS growth of 51.21% and a revenue growth 7.99% for OM
Over the last trailing twelve months OM reported a non-GAAP Earnings per Share(EPS) of -5.61. The EPS increased by 79.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.87% | ||
| ROE | -64.32% | ||
| Debt/Equity | 0.76 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.17 | 191.579B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.2 | 175.033B | ||
| SYK | STRYKER CORP | 22.57 | 132.327B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.72 | 103.323B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.47 | 49.378B | ||
| IDXX | IDEXX LABORATORIES INC | 39.73 | 47.813B | ||
| BDX | BECTON DICKINSON AND CO | 11.89 | 46.461B | ||
| RMD | RESMED INC | 19.26 | 34.985B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.68 | 33.11B | ||
| DXCM | DEXCOM INC | 25.99 | 25.52B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.16 | 18.338B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.834B | ||
| PODD | INSULET CORP | 36.89 | 16.813B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
IPO: 2020-09-15
OUTSET MEDICAL INC
3052 Orchard Drive
San Jose CALIFORNIA 95134 US
CEO: Leslie Trigg
Employees: 354
Phone: 16692318200
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
The current stock price of OM is 3.17 USD. The price decreased by -2.76% in the last trading session.
OM does not pay a dividend.
OM has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
OUTSET MEDICAL INC (OM) currently has 354 employees.
OUTSET MEDICAL INC (OM) has a market capitalization of 57.54M USD. This makes OM a Micro Cap stock.
The outstanding short interest for OUTSET MEDICAL INC (OM) is 13.15% of its float.